Log In
Print
BCIQ
Print
Print this Print this
 

doxorubicin (Livatag doxorubicin Transdrug) (BA-003)

  Manage Alerts
Collapse Summary General Information
Company BioAlliance Pharma S.A.
DescriptionNanoparticle formulation of doxorubicin
Molecular Target DNA
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationLiver cancer
Indication DetailsTreat advanced hepatocellular carcinoma (HCC); Treat hepatocellular carcinoma (HCC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today